UNMATCHED SUPPLY CHAIN SOLUTIONS FOR THE LIFE SCIENCES INDUSTRY

561
Active Clinical Trials
8
Commercial Products
425,000+
Shipments
150+
Countries
Cryoport_Q2_2021_Box 
whitepaper

Download our ISO 21973 white paper

A leap forward in standardizing the regenerative medicine supply chain

  • Ensuring full compliance at every step
  • Standardization at scale
  • Mitigating risk in a zero failure environment
LEARN MORE

The Latest From Our Blog View All

Courier Agnostic – Cryoport Systems’ Great Advantage

Are you experiencing the following 10 problems with your current logistics courier?

Introducing Cryoport BioServices: Providing a Stronger, Smarter Supply Chain Worldwide

One of the challenges facing the cell and gene therapy industry, as it grows and matures, is the development of robust supply chains to support the increase in clinical trials and the commercialization of new therapies on a global basis. Companies developing these new therapies need commercial partners to help support the scale up of manufacturing and delivery to patients across the world. The current infrastructure for controlled temperature storage, packaging and distribution of advanced therapies is widely regarded as insufficient. This is where Cryoport BioServices can help with the introduction of its new Global Supply Chain Centers.

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC

Exciting News! Cryoport, Inc., our parent company, has expanded its family of companies in continuing to support temperature controlled supply chain solutions for the life sciences industry. Learn More